| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2020-01-02 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 867 | $220.37 | $191,060.50 | -0.3% | → |
| 2019-12-24 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 1,130 | $222.12 | $250,999.23 | -0.4% | → |
| 2019-12-20 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 5,767 | $222.06 | $1,280,631.55 | -4.2% | → |
| 2019-12-20 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 5,767 | $222.06 | $1,280,631.55 | -4.2% | → |
| 2019-12-12 | Furlow Brenda S. | SVP - General Counsel | Sale+OE | 8,000 | $215.60 | $1,724,771.86 | -25.8% | → |
| 2019-12-10 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 703 | $222.01 | $156,073.03 | -0.5% | → |
| 2019-12-04 | WIENS HAROLD J | Director | Sale+OE | 2,000 | $217.85 | $435,692.83 | -7.8% | → |
| 2019-11-29 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 11,872 | $222.13 | $2,637,076.66 | -4.2% | → |
| 2019-11-25 | Nusse Roeland | Director | Sale+OE | 8,347 | $219.33 | $1,830,730.82 | -40.3% | → |
| 2019-11-22 | Hippel James | Chief Financial Officer | Sale+OE | 35,000 | $215.52 | $7,543,033.38 | -54.2% | → |
| 2019-09-09 | Kummeth Charles R. | Chief Executive Officer | Buy | 200 | $185.00 | $37,000.00 | New | → |
| 2019-08-07 | BAUMGARTNER ROBERT V | Director | Buy | 500 | $191.06 | $95,530.00 | +6.1% | → |
| 2019-07-10 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 16,969 | $213.12 | $3,616,428.34 | -5.6% | → |
| 2019-07-09 | Kummeth Charles R. | Chief Executive Officer | Sale+OE | 33,031 | $212.60 | $7,022,523.90 | -15.2% | → |
| 2019-06-12 | Eansor Norman David | SVP - Novus Biologicals | Sell | 3,117 | $215.00 | $670,155.00 | -100% | → |
| 2019-06-04 | HIGGINS JOHN L | - | Sale+OE | 5,000 | $203.67 | $1,018,345.50 | -58.6% | → |
| 2019-05-24 | Furlow Brenda S. | SVP - General Counsel | Sale+OE | 5,400 | $200.00 | $1,080,000.00 | -71.2% | → |
| 2019-05-01 | Hippel James | Chief Financial Officer | Sale+OE | 35,000 | $203.08 | $7,107,681.00 | -88.9% | → |
| 2018-08-24 | BAUMGARTNER ROBERT V | - | Sale+OE | 5,000 | $188.47 | $942,333.50 | -39.3% | → |
| 2018-08-23 | HIGGINS JOHN L | Director | Sale+OE | 10,000 | $187.92 | $1,879,173.00 | -76.9% | → |
| 2018-08-08 | Dinarello Charles A | - | Sale+OE | 5,000 | $176.94 | $884,675.00 | -37.8% | → |
| 2018-06-07 | Kummeth Charles R. | Chief Executive Officer | Sell | 8,000 | $160.00 | $1,280,000.00 | -9.5% | → |
| 2018-05-04 | Eansor Norman David | SVP - Novus Biologicals | Sell | 1,136 | $145.19 | $164,931.75 | -33.4% | → |
| 2018-02-13 | Dinarello Charles A | Director | Sale+OE | 5,000 | $136.06 | $680,303.00 | -20.9% | → |
| 2017-11-01 | BAUMGARTNER ROBERT V | - | Sale+OE | 5,000 | $130.18 | $650,907.00 | -39.3% | → |
| 2017-10-10 | LUCAS ROGER C | - | Sell | 100 | $121.96 | $12,195.50 | -5.1% | → |
| 2017-09-08 | LUCAS ROGER C | - | Sell | 100 | $120.94 | $12,093.83 | -4.8% | → |
| 2017-09-06 | HOLBROOK KAREN A | - | Sell | 1,059 | $121.73 | $128,909.10 | -53.7% | → |
| 2017-08-10 | LUCAS ROGER C | - | Sell | 100 | $114.30 | $11,430.00 | -4.6% | → |
| 2017-07-10 | LUCAS ROGER C | - | Sell | 100 | $116.86 | $11,686.00 | -4.4% | → |
| 2017-06-09 | LUCAS ROGER C | - | Sell | 100 | $113.62 | $11,362.00 | -4.2% | → |
| 2017-05-31 | Dinarello Charles A | - | Sale+OE | 5,000 | $111.37 | $556,861.50 | -40.1% | → |
| 2017-05-25 | HOLBROOK KAREN A | - | Sale+OE | 5,000 | $111.15 | $555,773.00 | -71.7% | → |
| 2017-05-22 | LUCAS ROGER C | - | Sell | 1,059 | $110.01 | $116,504.83 | -30.9% | → |